Skip to main content Accessibility help
  • Print publication year: 2015
  • Online publication date: April 2015

51 - Antibiotic-associated diarrhea

from Part VII - Clinical syndromes: gastrointestinal tract, liver, and abdomen
Suggested reading
Cohen, SH, Gerding, DN, Johnson, S, et al: Clinical practice guidelines for Clostridium difficile infection. Infect Control Hosp Epidemiol. 2010;31:431–455.
Centers for Disease Control and Prevention (CDC). Vital Signs: Preventing Clostridium difficile infection. MMWR Morb Mortal Wkly Rep. 2012;61:157–162.
Eyre, DW, Cule, ML, Wilson, DJ, et al. Diverse sources of Clostridium difficile infection identified on whole genome sequencing. N Engl J Med. 2013;369:1195–1205.
Loo, VG. Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med. 2011;365:1693–1703.
Louie, TJ, Miller, MA, Mullane, KM, et al. Fidaxomicin verses vancomycin for Clostridium difficile infection. N Engl J Med. 2011;364:422–431.
van Nood, E, Vriez, A, Nieuwdorp, M, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med. 2013;368:407–415.